. Average affinity profile plot of the insulin binding data from Figure  2 . Average affinity was calculated as (bound/free insulin)/(R0-B) and plotted as a function of fractional receptor occupancy (B/R0). R0 and B are molar concentration of total insulin binding capacity and bound insulin, respectively.
Since the mean value of specific binding at tracer insulin concentration was higher in the well controlled group than in the poorly controlled group, we examined the correlation between fasting blood glucose levels and spcific binding at tracer insulin concentration in diabetics and found a slight inverse correlation between these parameters (n=54, r=-0.30, p<0.02). However, there was no correlation between fasting blood glucose levels and receptor number or fasting plasma insulin levels and receptor number. We subdivided the diabetics according to the type of treatment (i.e. diettreated group and sulfonylurea-treated group) and compared the results of the binding studies. However, we could not find any significant differences between these two groups.
We found some of the results were affected by aging of 125I-insulin (data not shown). We performed, therefore, the experiments both in normal subjects and in diabetics almost on the same day using the same label (approximately 13 days after the iodination).
Discussion
The insulin receptor concentration in erythrocytes calculated from the Scatchard plots was significantly lower in diabetics than in age-matched healthy subjects. Although it has not been concluded whether the curvilinearity of the Scatchard plots is due to negative cooperativity among binding sites (De Meyts and Roth, 1975) or the existence of two or more classes of binding sites with different capacities and affinities (Pollet et al. 1977; Olefsky and Chang, 1979) or both of these factors, the Endocrinol. Japon. October 1981 total receptor number is the same whichever interpretation is preferred. have reported decreased insulin receptors on monocytes in patients with fasting hyperglycemia who have fasting hyperinsulinemia as a group but decreased insulin response to a glucose challenge. In their report, diabetic patients with normal fasting insulin levels had normal insulin binding. Also in previous reports of erythrocyte insulin receptors, fasting insulin levels of the patients were considerably increased (Robinson et al., 1979) or a negative correlation was found between fasting insulin levels and insulin binding (De Pirro et al., 1980) . Therefore, it is suggested that insulin receptors are decreased due to "down regulation".
However, in our study fasting insulin levels of nonobese diabetics were not different from controls but their insulin response to a glucose challenge was considerably decreased, as we have already reported (Kosaka et al., 1974; 1980) . These data suggest that the 24-h insulin levels in the diabetic patients in this study were lower than in control subjects. Thus, our results show that decreased insulin receptors on erythrocytes in diabetics cannot be explained by plasma insulin levels. The insulin receptor number in erythrocyte was never increased in spite of hypoinsulinemia.
Our results on receptor number in normal subjects were comparable to those of some other reports (Kappy and Plotnick, 1979; De Pirro, 1980) , but smaller than those of others (Gambhir mainly due to differences in interpretation rather than differences in data. We used an insulin concentration of 100ng/ml as a maximum insulin concentration in our Scatchard plots and this is the reason why we obtained somewhat smaller values than others, as stated by Kappy and Plotnick (1979) .
On the other hand, specific binding at tracer insulin concentration was comparable in diabetics and controls, and this is due to an increased affinity in spite of a decreased number of receptors in diabetics. Our results are not compatible with previous reports (Robinson et al., 1979 in the well controlled group was comparable to normal subjects at physiological insulin concentrations because of increased affinity but it is still decreased in poorly controlled group at 1.4ng/ml or more insulin concentrations.
In the well controlled group, the increased affinity and comparable amount of insulin bound might play a contributory role in improving the diabetic states, if the same change occurs in the major target tissues. However, it should be noted that we cannot tell which is the cause and which is the effect. Sulfonylurea therapy has been reported to be associated with a diminution in hyperglycemia and a concomitant return toward normal insulin binding of monocytes . It has been suspected that an increase in insulin binding might be related specifically with sulfonylurea therapy.
However, in our study of erythrocytes, no difference was found between diet-treated and sulfonylureatreated patients. Therefore, an increase in insulin binding might be associated with an improvement in the diabetic state and not specifically associated with sulfonylurea therapy. 
